|
Status |
Public on Dec 18, 2009 |
Title |
Patient 4 after folic acid |
Sample type |
RNA |
|
|
Source name |
peripheral blood
|
Organism |
Homo sapiens |
Characteristics |
disease: type 1 diabetes gender: male cell type: endothelial progenitor cell
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with Trizol reagent, followed by DNase I treatment (Amersam Biosciences) in accordance with the prescribed protocol provided by the manufacturer
|
Label |
cy3
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion Illumina® TotalPrepTM RNA Amplification Kit
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
patient 4 after folic acid
|
Data processing |
The data were normalized using quantile normalisation with IlluminaGUI in R and log2 transformed
|
|
|
Submission date |
Aug 13, 2009 |
Last update date |
Dec 18, 2009 |
Contact name |
Mario Pescatori |
E-mail(s) |
[email protected]
|
Phone |
00393930761013
|
Organization name |
Health e-genomics
|
Street address |
Westplein 11
|
City |
rotterdam |
ZIP/Postal code |
3016BM |
Country |
Netherlands |
|
|
Platform ID |
GPL2700 |
Series (1) |
GSE17635 |
Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes |
|